Approach to Acute Kidney Injury in a Patientwith HIV
DOI:
https://doi.org/10.71749/pkj.102Keywords:
Acute Kidney Injury, HIV InfectionsAbstract
.
Downloads
References
Glória L, Cravo M, Camilo ME, Resende M, Cardoso JN, Oliveira AG, et al. Nutritional deficiencies in chronic alcoholics: relation to dietary intake and alcohol consumption. Am J Gastroenterol. 1997 Mar;92(3):485–9.
Klomjit N, Ungprasert P. Acute kidney injury associated with non-steroidal anti-inflammatory drugs. European Journal of Internal Medicine. 2022 Jul;101:21–8.
Clive DM, Stoff JS. Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs. N Engl J Med. 1984 Mar;310(9):563–72.
Rivera FB, Ansay MFM, Golbin JM, Alfonso PGI, Mangubat GFE, Menghrajani RHS, et al. HIV-Associated Nephropathy in 2022. Glomerular Dis. 2023;3(1):1–11.
Satoskar AA, Parikh SV, Nadasdy T. Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nat Rev Nephrol. 2020 Jan;16(1):32–50.
Venter WDF, Fabian J, Feldman C. An overview of tenofovir and renal disease for the HIV-treating clinician. South Afr J HIV Med. 2018 Jul 17;19(1):817.
Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D’Agati VD, Markowitz GS. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. Kidney International. 2010 Dec 1;78(11):1171–7.
Hall AM, Hendry BM, Nitsch D, Connolly JO. Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis. 2011 May;57(5):773–80.
Kohler JJ, Hosseini SH, Hoying-Brandt A, Green E, Johnson DM, Russ R, et al. Tenofovir renal toxicity targets mitochondria of renal proximal tubules. Lab Invest. 2009 May;89(5):513–9.
Prendecki M, Tanna A, Salama AD, Tam FWK, Cairns T, Taube D, et al. Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids. Clin Kidney J. 2017 Apr;10(2):233–9.
Miao J, Thongprayoon C, Krisanapan P, Buglioni A, Craici IM, Cheungpasitporn W. Clinicopathological Characteristics and Kidney Outcomes in Biopsy-Confirmed Acute Interstitial Nephritis. Kidney Int Rep. 2024 Oct 10;9(12):3542–52.
González E, Gutiérrez E, Galeano C, Chevia C, de Sequera P, Bernis C, et al. Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int. 2008 Apr;73(8):940–6.
Wendt R, Schliecker J, Beige J. Inflammatory leucocyte infiltrates are associated with recovery in biopsy-proven acute interstitial nephritis: a 20-year registry-based case series. Clin Kidney J. 2019 Aug 3;12(6):814–20.
Kalyesubula R, Perazella MA. Nephrotoxicity of HAART. AIDS Res Treat. 2011;2011:562790.
Fülöp B, Fischer J, Hahn M, Böhlig A, Matz-Soja M, Berg T, et al. Prospective Analysis of Safety and Efficacy of Tenofovir Alafenamide Fumarate (TAF) in European Real-World Patients with Chronic Hepatitis B: A Single-Centre Real-World Cohort Study. Pathogens. 2024 Sep 23;13(9):820.
Hill A, Hughes SL, Gotham D, Pozniak AL. Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? Journal of Virus Eradication. 2018 Apr 1;4(2):72–9.
Downloads
Published
Data Availability Statement
No datasets were generated or analyzed during the current study. All relevant clinical information is included within the case report. Additional data are not publicly available to protect patient confidentiality.
Issue
Section
License
Copyright (c) 2025 Mariana Pais, Fernando Pereira, Tiago Assis Pereira, Ana Messias, Cristina Santos
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
